br Q , sot is longer than t Q − t c , the system never unfreezes, and thus the acceleration of the cooling has no effect on '. These results provide direct support for the KZ freeze-out hypothesis.
To accurately determine the KZ exponent b, we made extensive measurements following QP2, extracting ' from the plateaued regions of width min½t ; t Q −t c , as in Fig. 3C . In Fig. 4 , we combine these data with the QP1 measurements for t Q ≤1 s, and plot ' versus t Q . The plotted values of t Q and their uncertainties include the small systematic variation of the derivative of our cooling trajectory between t c and t c −t . We finally obtain b ¼ 0:35ð4Þ, which strongly favors the F-model prediction b ≈ 1=3 over the MF value b ¼ 1=4 (32).
Having observed excellent agreement with the KZ theory, we discuss the implications of our measurements for the critical exponents of the interacting BEC phase transition, which is in the same universality class as the l transition of 4 He. Whereas n ≈ 0:67 has been measured in both liquid helium [see (33)] and atomic gases (34), the dynamical exponent z has presented a challenge to experiments [see (2, 35) ]. Using the well-established n ¼ 0:67 and Eq. 2, we obtain z ¼ 1:4ð4Þ. In contrast, MF theory does not provide a self-consistent interpretation of our results, as fixing n ¼ 1=2 yields an inconsistent z ¼ 0:9ð4Þ. Interestingly, if we instead fix nz ¼ 1, which holds at both the MF and F-model levels, from Eq. 2 we obtain a slightly more precise z ¼ 1:4ð2Þ and also recover n ¼ 0:70ð8Þ.
It would be interesting to study the effect of tunable interactions in a homogeneous atomic gas on the value of b. According to the Ginzburg criterion, near the critical point, MF breaks down for x ≳ x G ¼ l 2 c =ð ffiffiffiffiffiffiffi 128 p p 2 aÞ, where a is the s-wave scattering length. It is tempting to combine the (dynamical) KZ and (equilibrium) Ginzburg arguments and speculate that one should observe the MF value of b if on approach to T c the KZ freeze-out occurs before MF breaks down, and the F value of b if the reverse is true. In our experiments, x G ≈ 0:8 mm and the freeze-out values of ' are systematically higher. However, with use of a Feshbach resonance, the opposite regime should be within reach. Another interesting study could focus on the dynamics of domain coarsening. Finally, our methods could potentially be extended to studies of higher-order correlation functions and the full statistics of the domain sizes. 22 . S. Ejtemaee, P. Haljan, Phys. Rev. A 87, 051401(R) (2013 commonly target conserved molecular patterns found on pathogens and commensals alike, yet healthy gut microbial communities can remain stable for years in humans (3). Because cationic antimicrobial peptides (AMPs) represent one of the most prominent and nonspecific components of the host response to pathogens, we determined the minimum inhibitory concentration (MIC) of polymyxin B (PMB) for a common human gut commensal, Bacteroides thetaiotaomicron. PMB is a bacterial cationic AMP with a mode of action similar to that of mammalian AMPs (4). Notably, this commensal exhibits 680-to 2400-fold increased resistance to PMB compared with mammalian enteropathogens or Escherichia coli (Fig. 1A, fig. S1 , and table S1). A survey of 17 prominent human commensals, representing the three major bacterial phyla in the gut (5), revealed that resistance against multiple inflammation-associated human and murine AMPs is a general feature of the human gut microbiota (Fig. 1B, fig. S1 , and table S1).
We screened transposon mutant populations of five human gut commensal species for genes required for fitness in the presence of PMB. This approach identified a single gene (encoded by BT1854 in B. thetaiotaomicron) that mediated PMB resistance in all species tested ( Fig. 2A and tables S2 to S4). Targeted deletion and complementation of BT1854 confirmed this phenotype for multiple AMPs ( Fig. 2B and table S1).
BT1854 has limited homology to the phospholipid biosynthetic enzyme PgpB, a phosphatidylglycerol phosphatase (6) that is not implicated in AMP resistance. However, an unusual PgpB homolog, LpxF, catalyzes the removal of the negatively charged 4′-phosphate group from the lipopolysaccharide (LPS) lipid A anchor in a small, phylogenetically heterogeneous group of AMPresistant pathogens (7) (8) (9) . Notably, B. thetaiotaomicron produces an underphosphorylated lipid A structure when compared to most Gram-negative organisms (10) Mass spectrometry (MS) analysis of lipid A extracted from B. thetaiotaomicron revealed a predominant peak at a mass-to-charge ratio (m/z) of 843.6, consistent with the published (10) doubly deprotonated ([M-2H] 2-) ion structure of penta-acylated 4′-dephosphorylated lipid A (predicted exact mass: 844.7m/z) (Fig. 2C) . By contrast, MS analysis of lipid A extracted from the B. thetaiotaomicron BT1854 deletion mutant revealed a peak consistent with the (M-2H)
2-ion of penta-acylated, bis-phosphorylated lipid A (predicted exact mass: 884.6 m/z) (Fig. 2C ). An additional minor peak consistent with a tetra-acylated structure is observed for all strains ( S2E ). Based on these results, we designated this protein as LpxF.
Characterization of wild-type and lpxF mutant strains showed that LpxF increased resistance to inflammation-associated AMPs by neutralizing the negative charge of the cell (Fig. 2D) , decreasing AMP binding at the bacterial surface ( Fig. 2E  and fig. S3A ), and reducing AMP-dependent membrane disruption (Fig. 2F and fig. S3B ).
If resistance to inflammation-associated AMPs determines Bacteroidetes fitness in the gut, then a strain with reduced AMP resistance should be outcompeted by an isogenic wild-type strain in a mammalian host during inflammation. We established a gnotobiotic model of gut inflammation by colonizing germ-free mice with a mixture of wild-type, lpxF deletion mutant, and complemented (lpxF,lpxF + ) B. thetaiotaomicron strains 7 days before infection with Citrobacter rodentium, a murine enteropathogen that mimics human gastrointestinal infection (11) , or an avirulent tir mutant incapable of inducing colitis ( fig. S4 , A to C) (12) .
We next monitored the relative abundance of each strain over time in these animals. The B. thetaiotaomicron lpxF deletion mutant was rapidly displaced by wild-type and lpxF,lpxF + complemented strains in mice infected with C. rodentium (Fig. 3A and table S5 ). Displacement occurred at the onset of inflammation (fig. S5, A and B) and concurrent with increased AMP secretion measured from colonic tissue explants ( fig. S5C ). By contrast, the lpxF deletion mutant was able to persist in mice that had not been infected with C. rodentium (Fig. 3B ) and in mice infected with the noninflammatory C. rodentium tir mutant, which colonizes the gut to levels similar to those of the wild-type pathogen (Fig. 3C) . The lpxF mutant was also outcompeted in gnotobiotic mice exposed to dextran sulfate sodium (DSS), a chemical inducer of intestinal inflammation, at the onset of inflammation ( Fig. 3D; fig.  S4 , A to C; and fig. S5 ). Exposure in vitro to numerous AMPs, but not C. rodentium or DSS, recapitulates the in vivo results (fig. S4, D and E) . LpxF thus appears to be a general determinant of resilience during inflammation and not a specific requirement for response to C. rodentium.
If resistance to AMPs is also important for resilience in the context of a multiphylum human gut microbiota residing in the mammalian gut environment, then a mutant sensitive to AMPs should exhibit a loss of resilience in this community. We colonized germ-free mice with 14 bacterial species, including wild-type B. thetaiotaomicron, that represent the three dominant phyla observed in the human gut (tables S6 to S8) (13) . Notably, this community remained largely stable through the SCIENCE sciencemag.org fig. S1 and table S1.
course of C. rodentium infection (Fig. 4A) and fig. S6A ). By contrast, in the absence of C. rodentium infection, both the B. thetaiotaomicron wild-type and lpxF mutant-containing communities remained stable for the duration of the experiment ( fig. S6B ).
Germ-free mice have an immature innate immune system (14) that is largely rescued by colonization with mouse, but not human, microbiota (15) . We tested whether B. thetaiotaomicron requires LpxF in animals with a complete mouse microbiota and a mature innate immune system. Because human gut Bacteroides spp. are rapidly outcompeted in specific pathogen-free (SPF) wild-type mice (16), we screened multiple strains of mice and found that B. thetaiotaomicron, like B. fragilis (16) , stably colonized SPF Rag −/− animals (Fig. 4C) . In these mice, the B. thetaiotaomicron lpxF deletion mutant colonized to levels equivalent to those of the wild type (Fig. 4C) . B. thetaiotaomicron resilience during C. rodentium infection of these SPF mice remained dependent on LpxF, indicating that the inflammation caused by pathogen infection, rather than other members of the commensal mouse microbiota, mediated the requirement for AMP resistance (Fig. 4D ). Many innate immune defects observed in germ-free mice are also abrogated by segmented filamentous bacteria (SFB), a mouse commensal that interacts directly with the gut epithelium (15) . The lpxF deletion mutant remained stable over time in gnotobiotic mice monoassociated with SFB, indicating that even a pure population of immunostimulatory commensal members of the host's native microbiota does not induce a requirement for AMP resistance ( fig. S6C ). LpxF orthologs are readily identified in all sequenced human-associated Bacteroidetes, and all characterized LPS structures in this phylum reveal an underphosphorylated lipid A structure ( fig. S7 ), suggesting that all human gut Bacteroidetes use this mechanism to resist inflammatory perturbations. We conducted a human study to determine whether our observations from sequenced type strains extend to gut commensals captured directly from humans. To this end, we cultured 733 species-level phylotypes from 12 unrelated, healthy donors (table S9) . These cultured strains represent~98% of the donors' original, uncultured communities at the phylum level,~95% at the class and order levels,~80% at the family level, and~50% at the genus level ( fig. S8A ). Quantification of PMB resistance across these culture collections established that the AMP resistance profiles of fecal microbial communities isolated directly from humans mirror the phylum-level patterns observed in sequenced type strains (Fig.  4E and fig. S8B ).
Understanding mechanisms of microbiota stability is important for efforts to manipulate these communities for therapeutic purposes. We found that the ability of prominent human gut commensal bacteria to resist killing by AMPs also mediated stability during infection. This resilience hinges on a protein that removes a single phosphate group from the bacterial LPS to determine whether the host maintains or removes commensal bacteria in response to inflammation. In this way, commensal-encoded mechanisms for persistence in the host during inflammation complement host-encoded mechanisms for immune tolerance of the microbiota (17) . As observed in certain pathogens, lipid A modification may provide additional benefits to commensal microbes beyond AMP resistance, including reduced activation of the host Toll-like receptor 4-myeloid differentiation factor 2 (TLR4-MD2) complex that recognizes common forms of bacterial LPS (7, 8, 10, (18) (19) (20) (21) (22) (23) . Our studies indicate Fig. 3 . AMP resistance determines the resilience of a prominent human gut symbiont in gnotobiotic mice with colitis. Germ-free mice (n = 5 per group) were colonized with wild-type, the lpxF deletion mutant (solid lines), and complemented (lpxF,lpxF + ; dashed lines) B. thetaiotaomicron strains 7 days before initiation of inflammation by C. rodentium infection (A); no further treatment (B), infection with a noninflammatory C. rodentium tir mutant (C), or exposure to 3% DSS ad libitum for 7 days (black bar) (D). Infection with C. rodentium strains is indicated by black arrowheads, and relative C. rodentium abundances are reported as percentage of total fecal DNA (shaded bars); error bars represent SD and asterisks indicate significant (P < 0.01) differences.
sciencemag.org SCIENCE Parasitic worms modulate host immune responses in ways that affect microbial co-infections. For this reason, anthelmintic therapy may be a potent tool for indirectly controlling microbial pathogens. However, the population-level consequences of this type of intervention on co-infecting microbes are unknown. We evaluated the effects of anthelmintic treatment on bovine tuberculosis (BTB) acquisition, mortality after infection, and pathogen fitness in free-ranging African buffalo. We found that treatment had no effect on the probability of BTB infection, but buffalo survival after infection was ninefold higher among treated individuals. These contrasting effects translated into an approximately eightfold increase in the reproductive number of BTB for anthelmintic-treated compared with untreated buffalo. Our results indicate that anthelmintic treatment can enhance the spread of microbial pathogens in some real-world situations.
H elminths are among the most ubiquitous parasites on earth, infecting more than 1 billion people (1) and causing substantial production losses in livestock (2) . Because chronic helminth infection can modulate host immune responses, there is considerable interest in the role helminth infection may play in the progression of co-infecting microbial diseases (3, 4) . In the laboratory, mouse and nonhuman primate studies show that helminths can skew host immunity in ways that alter the outcomes of viral and bacterial infections (5-7). Specifically, T helper cell 2 (T H 2) responses triggered by helminths can bias the mammalian immune responses away from antiviral or antibacterial T H 1 responses, increasing host vulnerability to certain intracellular pathogens. Some human studies have also linked helminth coinfection to enhanced morbidity for other infectious diseases, such as tuberculosis and HIV (8) (9) (10) (11) . Although individual studies suggest that the specific outcomes of helminth coinfection can vary by pathogen system, important trends have emerged linking concurrent helminth infection to changes in host responses to microbial infections (4) . This general observation has triggered calls for integrating anthelmintic treatment into control efforts for some microbial diseases of humans as a means of improving disease outcomes (12) (13) (14) . However, few data exist to show how such individual-level interventions might affect population-level disease patterns of target microbes.
We used a wild population of African buffalo (Syncerus caffer), naturally infected with gastrointestinal helminths (strongyle nematodes of various species) and exposed to bovine tuberculosis (BTB, Mycobacterium bovis), to investigate the consequences of anthelmintic treatment on BTB dynamics (15) . Patterns of BTB and nematode infection in buffalo indicate strong immune-mediated interactions between the two parasites (16). Moreover, short-term anthelmintic treatment of buffalo has been shown to increase T H 1 immunity, demonstrating that helminth-mediated immune suppression occurs in this species (17) . By monitoring a cohort of more than 200 anthelmintictreated and control animals, we tested for the effects of treatment on immunity, BTB infection probability, and BTB-associated mortality and then explored the implications of treatment for the fitness of M. bovis, as measured by this pathogen's reproductive number (15) . We found that treatment improved the survival of individual hosts infected with BTB but also enhanced pathogen fitness.
We captured 216 female African buffalo in Kruger National Park, South Africa, approximately every 182 days over a 4-year period. At capture, animals in the experimental group (n = 108) received a long-lasting anthelmintic bolus (Panacur, Intervet, UK), whereas controls (n = 108) were left untreated. At the beginning of the experiment, all of these animals were BTB-free. Before anthelmintic treatment, the treated and control groups did not differ in their likelihood of being infected with worms (control = 57 of 103; treated = 55 of 107; Pearson's c 2 test, c 2 = 0.33, P = 0.57) nor in the number of worm eggs they were shedding in feces (Wilcoxon rank sum test, Z = 1.16, P = 0.25). After treatment, treated individuals were less likely to be infected with worms [generalized linear mixed model (GLMM), n = 214 individuals, 1134 observations, b estimate T SE (control) = 1.69 T 0.27, P < 0.0001 ( 
